SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-045119
Filing Date
2015-06-12
Accepted
2015-06-12 15:50:37
Documents
9
Period of Report
2015-04-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-12488_110q.htm 10-Q 481165
2 EX-31.1 a15-12488_1ex31d1.htm EX-31.1 17659
3 EX-32.1 a15-12488_1ex32d1.htm EX-32.1 4093
  Complete submission text file 0001104659-15-045119.txt   3798397

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT bpmx-20150430.xml EX-101.INS 519324
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bpmx-20150430.xsd EX-101.SCH 28418
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bpmx-20150430_cal.xml EX-101.CAL 37437
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bpmx-20150430_lab.xml EX-101.LAB 265041
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bpmx-20150430_pre.xml EX-101.PRE 208051
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bpmx-20150430_def.xml EX-101.DEF 95571
Mailing Address 1098 HAMILTON COURT MENLO PARK CA 94025
Business Address 1098 HAMILTON COURT MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 15928422
SIC: 1700 Construction - Special Trade Contractors